Original news and analysis on international IP policy
The first global target on noncommunicable diseases has been gavelled through a World Health Assembly meeting. Member states have decided on a voluntary global target in reducing overall mortality from cardiovascular disease, cancer, diabetes or chronic respiratory disease.
The latest available documents of the closed-door meeting addressing recommendations on ways to finance neglected diseases largely afflicting developing countries show progress heading into this afternoon's session. They reflect efforts to agree on how to take the process forward, including agreement reached last night on putting the issue to regional groups later this year.
A set of documents in use by today's closed-door negotiations on research and development for neglected diseases at the World Health Assembly lay out the core differences between WHO members. Negotiations are expected to last into the night as members try to agree on how to take forward recommendations from a key report - including to negotiate a binding convention on R&D for diseases left behind in the marketplace.
Members of the World Health Organization at their annual meeting tomorrow will address proposals for ways to finance research and development for diseases which afflict mainly developing countries but for which there are not lucrative markets.
The annual World Health Assembly being held this week has a rare chance to achieve a breakthrough on health research for the global poor if it can agree to move forward on a proposed convention, proponents said at a recent meeting.
The escalating battle between Big Pharma and India’s generic drug manufacturers is pushing down medicine prices in one of the world’s fastest growing pharmaceutical markets.
The Drugs for Neglected Diseases initiative (DNDi) has released a policy brief in support of the proposed R&D convention to be considered at the upcoming World Health Assembly.
With the launch of a new report concerning research and development for diseases predominately afflicting developing countries, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today convened a panel of public health specialists to discuss the findings.
In this post, three US law professors explain a recent call by over 30 legal scholars for the US Trade Representative to increase transparency for the Trans-Pacific Partnership Agreement intellectual property chapter, and their response to Ambassador Kirk’s response that he is “strongly offended” by the suggestion that the negotiation is not adequately transparent already.
A new draft proposal suggests that World Health Organization members postpone negotiations for a convention on financing of research and development for diseases predominantly afflicting poor populations. The negotiation of a convention is up for discussion by members at the annual World Health Assembly this month.
Eben Moglen, a professor of law and history at Columbia University, made a haunting appeal to participants of the 6th re:publica conference that opened in Berlin this morning: Do not to fail in completing the fight for freedom of thought.
Intellectual property rights have been around for centuries in some cultures, but in recent decades have taken off as a global set of rules, bringing with it many business opportunities and policy concerns. Today, on the annual day designated for the celebration of IP rights, some new industry and civil society initiatives were launched and several gatherings in praise of IP were held.